CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 165 filers reported holding CHEMOCENTRYX INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $286,000 | +39.5% | 16,747 | +227.5% | 0.03% | -43.1% |
| Q1 2020 | $205,000 | -70.8% | 5,114 | -71.2% | 0.05% | -37.8% |
| Q4 2019 | $702,000 | +24.5% | 17,738 | -70.7% | 0.08% | +30.2% |
| Q2 2019 | $564,000 | -55.6% | 60,622 | -33.7% | 0.06% | -51.2% |
| Q1 2019 | $1,270,000 | +8.0% | 91,400 | -15.2% | 0.13% | -5.1% |
| Q4 2018 | $1,176,000 | -43.5% | 107,800 | -34.6% | 0.14% | +18.3% |
| Q3 2018 | $2,083,000 | +152.2% | 164,800 | +162.8% | 0.12% | +180.5% |
| Q2 2018 | $826,000 | – | 62,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |